Bristol-Myers Squibb Foundation Joins White House Cancer Moonshot
October 17 2016 - 12:15PM
Business Wire
$25MM in funding will expand scope of
community-based cancer treatment, care and support for underserved
patients
Today the Bristol-Myers Squibb Foundation joins the White House
Cancer Moonshot initiative through its commitment to addressing
health disparities in cancer care. In response to the Cancer
Moonshot, the Foundation is committing $25 million in new funding
to grantee partners to expand the current scope of community-based
resources and survivorship support programs to underserved
populations in the U.S. The Cancer Moonshot is led by Vice
President Joe Biden with a goal of making a decade worth of
advances in cancer prevention, diagnosis, and treatment, in five
years.
“The Vice President’s Moonshot Initiative is vitally important
for patients living with cancer and their families,” said Giovanni
Caforio, Bristol-Myers Squibb Chief Executive Officer and chairman
of the Bristol-Myers Squibb Foundation board of directors. “We are
dedicated to fighting cancer and are excited to join this
collective effort to defeat this deadly disease, once and for
all.”
At the White House event, the Bristol-Myers Squibb Foundation
announced five partnership grants under this new commitment at the
White House Cancer Moonshot event: Project ECHO, American Cancer
Society, University of South Carolina College of Nursing, West
Virginia University Cancer Institute and the Mississippi Public
Health Institute. The remaining funding will be awarded over the
next two years.
As part of the Cancer Moonshot commitment, the Foundation
awarded a $10 million grant to Project ECHO (Extension for
Community Healthcare Outcomes), a multiyear initiative, to bring
top-quality care to cancer patients living in rural and underserved
areas where cancer specialists are not readily available and to
improve cancer health outcomes through pairing doctors at National
Cancer Institute-designated Comprehensive Cancer Centers and
academic medical centers with those in community hospitals and
health centers. The Foundation will also fund the American Cancer
Society, University of South Carolina College of Nursing, West
Virginia University Cancer Institute and the Mississippi Public
Health Institute to develop, deliver and evaluate innovative models
of comprehensive, coordinated care that meet the needs of survivors
of lung cancer, their family members and caregivers. Each partner
was awarded $750,000 over two years to develop interdisciplinary,
patient-centered survivorship care services.
“Our mission to address health disparities strongly complements
the Moonshot goal of accelerating breakthroughs in cancer
prevention, treatment options and care,” says John Damonti,
president of the Bristol-Myers Squibb Foundation. “The projects we
support specifically focus on populations that are both underserved
and at high risk for cancer. Our aim is to develop best practices
for strengthening clinic and community cancer services and support
systems so that breakthroughs can benefit everyone.”
In addition to the funding commitment announced today, the
Bristol-Myers Squibb Foundation has since 2014, committed more than
$27 million to 15 grantee partners to address disparities in access
to cancer services and health outcomes for vulnerable, low-income
and medically underserved people. Many of these grants were made
under the Foundation’s Bridging Cancer Care program that seeks to
reduce the burden of lung cancer through innovative models of
prevention, detection and education, and by helping people living
with lung cancer access and navigate cancer care and
community-based supportive services. Known as the Tobacco belt, the
region of focus is the southeastern states with the highest lung
cancer and mortality rates in the U.S. – Kentucky, Tennessee, West
Virginia, North and South Carolina, Alabama and Mississippi.
In 2015, the Foundation launched a new initiative to address
inequities in access to specialty care services including cancer by
vulnerable populations in the U.S. The goal of this national
initiative is to catalyze sustainable improvement and expansion of
specialty care service delivery by safety net providers to achieve
more optimal and equitable outcomes for the people they serve with
lung and skin cancer, as well as other diseases.
About the Bristol-Myers Squibb Foundation
The mission of the Bristol-Myers Squibb Foundation is to promote
health equity and improve the health outcomes of populations
disproportionately affected by serious diseases and conditions, by
strengthening community-based health care worker capacity,
integrating medical care and community-based supportive services,
and mobilizing communities in the fight against disease. For more
information about the Bristol-Myers Squibb Foundation, please visit
www.bms.com/foundation or follow us on LinkedIn, Twitter, YouTube
and Facebook.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161017006093/en/
Media:Bristol-Myers Squibb FoundationLisa McCormick
Lavery, 609-252-7602lisa.mccormicklavery@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Feb 2024 to Mar 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2023 to Mar 2024